Oxcarbazepine: an update of its efficacy in the management of epilepsy.
about
Oxcarbazepine versus phenytoin monotherapy for epilepsyClinical pharmacology and therapeutic use of the new antiepileptic drugs.Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.Brain tumor-related epilepsy.Oxcarbazepine in the treatment of bipolar disorder: a review.Value of therapeutic drug monitoring in epilepsy.Overnight transition from carbamazepine to oxcarbazepine in children and adolescents.Patients with brain tumor-related epilepsy.Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study.Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.Thirteen years of oxcarbazepine exposures reported to US poison centers: 2000 to 2012.Transplacental passage of oxcarbazepine and its metabolites in vivo.Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study.Evaluation of the Effects of Ketoconazole and Voriconazole on the Pharmacokinetics of Oxcarbazepine and Its Main Metabolite MHD in Rats by UPLC-MS-MS.Effects of oxcarbazepine on monoamines content in hippocampus and head and body shakes and sleep patterns in kainic acid-treated rats.Oxcarbazepine monotherapy in patients with brain tumor-related epilepsy: open-label pilot study for assessing the efficacy, tolerability and impact on quality of life.A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients.Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.
P2860
Q24202768-F94EEF5D-1170-4FF0-8FC0-BD0A68D9E650Q34541736-85B3B44E-EB35-4228-9394-4E96698DEE67Q34579633-47FE0A6F-BEED-4445-99A7-C2A063E498FAQ36067319-1C7C43D8-7A4F-460F-BB52-B130DF9941F3Q36577870-0F84C75B-83CD-4873-946D-9B08F0A7EBC8Q37174056-002F6705-FA8E-4198-9BF1-5FC0EA4E0A4AQ37281567-5FF4B1AD-AA18-4DED-AE56-601DB82FAAE5Q38005050-F186CCBF-B6D1-48B0-A7AD-530C8782E479Q39351750-15F833EC-648C-44D4-A6FC-4AFF66C1FFDAQ39362494-3C3E2F9B-5A91-4946-A936-82D0F4E40027Q40268875-09393F9F-4587-4AF0-8099-45F5B0A9BBBDQ43906050-933A364E-A0D4-4A67-9014-06E27D4DC0CDQ45059187-DE9B2368-51B1-4888-BA0C-017E1DEE1C9AQ45172659-15D08EAD-03DE-4023-A16E-002B144FEDB7Q47635280-CB92FC4B-5CAB-4FE3-AC2E-939996FAB958Q48291619-9E173CD3-C22E-4062-BE36-A9DCC7D48135Q48610473-ABD1FF3C-72A1-42CB-B9F5-7FA095D279DDQ50113769-B6C88FA5-C7D4-4F60-8FC3-9C7A528AAA3BQ53301415-BE22822C-5F38-49E9-9B0C-EB121D43C704
P2860
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@ast
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@en
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@nl
type
label
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@ast
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@en
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@nl
prefLabel
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@ast
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@en
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@nl
P1433
P1476
Oxcarbazepine: an update of its efficacy in the management of epilepsy.
@en
P2093
P304
P356
10.2165/00023210-200115020-00005
P577
2001-01-01T00:00:00Z
P6179
1017668061